Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Fenja Seither"'
Autor:
Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, Fenja Seither, Jens-Uwe Blohmer, Carsten Denkert, Hans Tesch, Claus Hanusch, Christoph Salat, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Christian Jackisch, Mattea Reinisch, Bianca Lederer, Keyur Mehta, Theresa Link, Valentina Nekljudova, Sibylle Loibl, Michael Untch
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract This retrospective pooled analysis aims to identify factors predicting relapse despite a pathologic complete response (pCR) in patients with breast cancer (BC). 2066 patients with a pCR from five neoadjuvant GBG/AGO-B trials fulfill the incl
Externí odkaz:
https://doaj.org/article/1894262e05954747a7b2989d697dd085
Autor:
Bernd Gerber, Andreas Schneeweiss, Volker Möbus, Michael Golatta, Hans Tesch, David Krug, Claus Hanusch, Carsten Denkert, Kristina Lübbe, Jörg Heil, Jens Huober, Beyhan Ataseven, Peter Klare, Markus Hahn, Michael Untch, Karin Kast, Christian Jackisch, Jörg Thomalla, Fenja Seither, Jens-Uwe Blohmer, Kerstin Rhiem, Peter A. Fasching, Valentina Nekljudova, Sibylle Loibl, Thorsten Kühn
Publikováno v:
Cancers, Vol 14, Iss 3, p 521 (2022)
Background: The conversion of initially histologically confirmed axillary lymph node-positive (pN+) to ypN0 after neoadjuvant systemic treatment (NAST) is an important prognostic factor in breast cancer (BC) patients and may influence surgical de-esc
Externí odkaz:
https://doaj.org/article/17e84cdca4604002ae0a7a1cf9a85dd2
Autor:
Jens-Uwe, Blohmer, Theresa, Link, Mattea, Reinisch, Marianne, Just, Michael, Untch, Oliver, Stötzer, Peter A, Fasching, Andreas, Schneeweiss, Pauline, Wimberger, Sabine, Seiler, Jens, Huober, Marc, Thill, Christian, Jackisch, Kerstin, Rhiem, Christine, Solbach, Claus, Hanusch, Fenja, Seither, Carsten, Denkert, Knut, Engels, Valentina, Nekljudova, Sibylle, Loibl, John, Hackmann
Publikováno v:
JAMA Oncol
IMPORTANCE: Adjuvant denosumab might improve disease-free survival in hormone receptor (HR)–positive primary breast cancer (BC). The optimal neoadjuvant nab-paclitaxel schedule in terms of efficacy and safety is unclear. OBJECTIVE: To determine whe
Autor:
Toralf Reimer, Wolfgang Janni, Hans Tesch, Kristina Lübbe, Theresa Link, Carsten Denkert, Marianne Just, Jenny Furlanetto, Frederik Marmé, Erich Solomayer, Christian Jackisch, Wolfgang D. Schmitt, Kerstin Rhiem, Mattea Reinisch, Fenja Seither, A Forberger, Peter A. Fasching, Bruno Valentin Sinn, Michael Untch, Sibylle Loibl, Claus Hanusch, Valentina Nekljudova, Christine Solbach, Jens-Uwe Blohmer, Sabine Seiler, Sabine Schmatloch, Andreas Schneeweiss, Elmar Stickeler, Pauline Wimberger, Jens Huober, Marcus Schmidt, Laura Michel, Oliver Stötzer, Eric Hahnen
Publikováno v:
The Lancet Oncology. 22:1151-1161
Summary Background The development of anti-HER2 antibody–drug conjugates opens new therapeutic options for patients with breast cancer, including patients with low expression of HER2. To characterise this new breast cancer subtype, we have compared
Autor:
Heikki Joenssuu, Juan José Miralles, Harry D. Bear, Fenja Seither, Miguel Martin, Toralf Reimer, Ulrike Nitz, Michael Untch, Hymann Muss, Volker Möbus, Marion van Mackelenbergh, Valentina Nekljudova, Sibylle Loibl, Joyce O'Shaugnessy, Masakazu Toi
Publikováno v:
Cancer Research. 80:GS1-07
Background: Despite the large number of patients with early breast cancer (EBC) that have been treated with capecitabine in randomized trials no individual patient data meta-analysis has yet been conducted. So far only two literature-based meta-analy
Autor:
Christina Bechtner, Hanne Lefrère, Andreas Schneeweiss, Sabine Schmatloch, Frédéric Amant, Valentina Nekljudova, Charlotte Maggen, Elyce Cardonick, Fenja Seither, Sibylle Loibl, Patrick Neven, Ingrid A. Boere, Jorine de Haan, Christine Solbach, Mina Mhallem Gziri, Tatjana Cordes, Sabine Seiler, Christianne A.R. Lok, Kristel Van Calsteren, Isabell Witzel
Publikováno v:
European Journal of Cancer, 170, 54-63. Elsevier Ltd.
European Journal of Cancer, 170, 54-63. Elsevier Limited
European journal of cancer (Oxford, England : 1990), Vol. 170, no.1, p. 54-63 (2022)
European Journal of Cancer, 170, 54-63. Elsevier Limited
European journal of cancer (Oxford, England : 1990), Vol. 170, no.1, p. 54-63 (2022)
515 Background: Overall a diagnosis of breast cancer during pregnancy (BCP) appears not to impact maternal prognosis if standard treatment is offered. However, caution is warranted as gestational changes in pharmacokinetics with respect to the distri
Autor:
Marion T. van Mackelenbergh, Fenja Seither, Volker Möbus, Joyce O'Shaughnessy, Miguel Martin, Heikki Joensuu, Michael Untch, Ulrike Nitz, Guenther G. Steger, Juan J. Miralles, Carlos H. Barrios, Masakazu Toi, Harry D. Bear, Hyman Muss, Toralf Reimer, Valentina Nekljudova, Sibylle Loibl
Publikováno v:
European journal of cancer (Oxford, England : 1990). 166
Despite the large number of patients with early breast cancer (EBC) who have been treated with capecitabine in randomised trials, no individual patient data meta-analysis has been conducted. The primary objective was to examine the effect of capecita
Autor:
Jens Uwe Blohmer, Mahdi Rezai, Ilka Schwidde, Marc Thill, Johannes Holtschmidt, Jana Mulowski, Christian Schem, Bernd Gerber, Albert Von der Assen, Klara Uhrhan, Valentina Nekljudova, Gunter von Minckwitz, David Krug, Sherko Kuemmel, Sibylle Loibl, Joerg Heil, Juliane Lubitz, Fenja Seither, Mattea Reinisch, Carsten Denkert, T. Kuehn, Michael Hötzeldt
Publikováno v:
Journal of Clinical Oncology. 37:1490-1498
PURPOSE The aim of the current work was to clarify whether a preoperative lymphoscintigraphy (LSG) enhances staging accuracy of sentinel lymph node biopsy (SLNB). PATIENTS AND METHODS In a prospective, multicenter, randomized phase III trial, patient
Autor:
Keyur Mehta, Hans Tesch, Michael Untch, K Rhiem, J-U Blohmer, J Huober, C. Solbach, Andreas Schneeweiss, Mahdi Rezai, Christoph Salat, S. Loibl, PA Fasching, G. von Minckwitz, C. Jackisch, C Denkert, Valentina Nekljudova, Fenja Seither, Claus Hanusch
Publikováno v:
Cancer Research. 79:P2-08
Background Even though patients with a pCR following neoadjuvant chemotherapy have an excellent prognosis still some of these patients will eventually relapse. A better identification of pts with an increased risk of relapse despite a pCR would be he
Autor:
Sabine Schmatloch, Michael Untch, Bruno Valentin Sinn, Toralf Reimer, Mattea Reinisch, F Marmé, C Bechtner, Wolfgang Janni, Elmar Stickeler, Sabine Seiler, M Wagner, T Neunhöffer, Martina Schmidt, S. Loibl, Volker Möbus, A. Kleine-Tebbe, Fenja Seither
Publikováno v:
Cancer Research. 79:P1-17
Introduction Breast cancer diagnosed in young women who are 40 years (yrs) or younger is a relatively rare disease. However, it represents the most common cause of cancer-related deaths in this age-group. Furthermore, young age at diagnosis is associ